- Formosa Plastics reported sales of NT$16.64 billion for September 2024.
- Sales slightly increased by 0.3% compared to September 2023.
- The sales growth percentage is precisely 0.32% year over year.
- Current market analyst recommendations for Formosa Plastics include:
- 2 analysts recommend buying the stock.
- 9 analysts suggest holding the stock.
- 3 analysts advise selling the stock.
- The sales data comparisons are based on previous reports from the company’s original disclosures.
A look at Formosa Plastics Smart Scores
Factor | Score | Magnitude |
---|---|---|
Value | 5 | |
Dividend | 3 | |
Growth | 2 | |
Resilience | 3 | |
Momentum | 3 | |
OVERALL SMART SCORE | 3.2 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Formosa Plastics Corporation, a company that focuses on manufacturing and marketing plastics materials and chemical fiber products, has received a high Smartkarma Smart Score for its value. This indicates a positive long-term outlook for the company’s overall worth in the market. Additionally, Formosa Plastics has achieved moderate scores in dividend, resilience, and momentum, reflecting a balanced performance across these factors. However, its growth score is relatively lower, suggesting potential areas for improvement in expanding its operations and increasing market share.
With a strong emphasis on producing PVC resins, high-density polyethylene, acrylic fiber, and various other chemical products, Formosa Plastics appears well-positioned to leverage its value and continue offering stable dividends to investors. While there may be room for enhancing growth prospects and momentum, the company’s resilience score indicates a certain level of stability that could benefit long-term investors seeking consistent returns in the plastics manufacturing sector.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
π‘ Before itβs here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- β Unlimited Research Summaries
- β Personalised Alerts
- β Custom Watchlists
- β Company Analytics and News
- β Events & Webinars